The clinical network behind every minus10med protocol
minus10med works with partners chosen for clinical seriousness. Diagnostics and therapies are delivered at Notia MedCare, a multidisciplinary medical centre in Glyfada, Athens. Norwegian Pharma supplies pharmaceutical-grade supplementation between visits, and NAD Clinic protocols inform the intravenous NAD+ therapy we prescribe and monitor.
Where are minus10med diagnostics and treatments performed?
At Notia MedCare, our clinical partner in Glyfada on the Athenian Riviera. It is a four-level multidisciplinary medical centre with more than twenty medical specialties, advanced imaging, an in-house laboratory and dedicated regenerative therapy suites under a single roof.
That last detail is not architectural trivia. When imaging, laboratory work, dermatology and therapy occur in one building, samples do not travel, appointments do not fragment across a city, and results land in one shared record on the same day. One building, one data picture, one team around you, which is what makes a single-day diagnostic schedule possible at all.
The address is 127 Vouliagmenis Avenue, 16674 Glyfada, Athens, and directions, parking and consultation formats are on the contact page.
Who supplies the supplements you prescribe?
Norwegian Pharma provides pharmaceutical-grade, marine-sourced supplementation from Norway: omega-3 formulations, collagen and targeted micronutrients. These are the products that carry your protocol between clinic visits, which is where most of the year happens.
Supplementation is prescribed against measured deficiency and your pharmacogenomic profile, not sold as a standing package. Purity, dose accuracy and batch traceability are the reason for a pharmaceutical supplier rather than a consumer brand: if a protocol is supposed to move a biomarker in twelve weeks, the input has to be as controlled as the measurement.
Who is behind the NAD+ infusion protocols?
NAD Clinic are international specialists in intravenous NAD+ therapy. Their protocols inform the infusion programmes we prescribe and monitor in Athens, including dose escalation, infusion duration and the tolerance management that makes the difference between a productive course and an unpleasant afternoon.
NAD+ sits in our detoxification and recovery family alongside vitamin C, B-complex and anti-inflammatory infusions, all described on the regenerative therapies page. As with every therapy here, the evidence level is stated honestly and the course is bracketed by biomarkers.
How do you choose a partner?
One quality: clinical seriousness. A partner has to accept physician oversight of what it contributes, share data in a form that enters your record rather than a PDF that nobody reads, and be willing to have the limits of its own evidence described plainly to patients.
We do not accept commissions that would influence a prescription, and no partner decides what appears in your protocol. The physician who reads your data decides, which is the whole point of the arrangement and is described on the Dr. Erietta Galani profile.
Are laboratory and imaging results shared between partners?
Within the clinical partnership, yes, and only to the extent needed to treat you. Imaging performed at Notia MedCare, laboratory analyses and specialist reviews return to one record held under Greek and EU data protection law. Nothing is shared with employers, insurers or third-party analytics, and the VIP tier adds an additional layer of scheduling privacy described on the VIP AI-Guided Diagnostics page.
If you want to see how the network translates into a specific plan and a specific price, every tier is listed on the programs and pricing page.
Why does a longevity clinic need partners at all?
Because longevity medicine is a reading discipline before it is a treating one, and reading requires instruments no single practice should pretend to own. A whole body MRI scanner, an accredited genomics laboratory, a dermatology department and a regenerative therapy suite each demand their own staffing, maintenance and quality assurance. A clinic that claims all of them in-house is usually either very large or describing something smaller than it sounds.
The alternative most patients experience is fragmentation: an imaging appointment in one district, bloods in another, a dermatology referral three weeks later, and four reports that never meet. Nobody synthesises them, so the patient does, badly, at midnight, with a search engine.
Our arrangement is deliberately narrow. A small number of partners, each excellent at one thing, all reporting into a single record that one physician reads. That is what allows the five-part Longevity Panel to be delivered in a day or two rather than a quarter, and it is what makes an annual re-test comparable with last year rather than merely adjacent to it.
It also sets a limit we take seriously: if a service cannot be delivered to that standard, we do not offer it and we say why. Patients are told which parts of their protocol rest on decades of clinical use and which rest on early research, and that honesty extends to the network delivering it.